The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells

Samia S. Messeha; Najla O. Zarmouh; Patricia Mendonca; Hayfaa Alwagdani; Malak G. Kolta; Karam F. A. Soliman

doi:10.1371/journal.pone.0201116

Loading metrics

Open Access

Peer-reviewed

Research Article

The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells

Samia S. Messeha,

Roles Conceptualization, Formal analysis, Methodology, Resources, Software, Writing – original draft, Writing – review & editing

Affiliation College of Pharmacy and Pharmaceutical Science, Florida A & M University, Tallahassee, Florida, United States of America
⨯
Najla O. Zarmouh,

Roles Formal analysis, Methodology, Resources, Software, Writing – review & editing

Affiliation College of Pharmacy and Pharmaceutical Science, Florida A & M University, Tallahassee, Florida, United States of America
⨯
Patricia Mendonca,

Roles Formal analysis, Methodology, Resources, Software, Writing – review & editing

Affiliation College of Pharmacy and Pharmaceutical Science, Florida A & M University, Tallahassee, Florida, United States of America
⨯
Hayfaa Alwagdani,

Roles Methodology

Affiliation College of Pharmacy and Pharmaceutical Science, Florida A & M University, Tallahassee, Florida, United States of America
⨯
Malak G. Kolta,

Roles Writing – review & editing

Affiliation College of Pharmacy and Pharmaceutical Science, Florida A & M University, Tallahassee, Florida, United States of America
⨯
Karam F. A. Soliman

Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Software, Supervision, Writing – review & editing

* E-mail: karam.soliman@famu.edu

Affiliation College of Pharmacy and Pharmaceutical Science, Florida A & M University, Tallahassee, Florida, United States of America

http://orcid.org/0000-0002-0600-1085

⨯

The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells

Samia S. Messeha,
Najla O. Zarmouh,
Patricia Mendonca,
Hayfaa Alwagdani,
Malak G. Kolta,
Karam F. A. Soliman

Published: July 30, 2018
https://doi.org/10.1371/journal.pone.0201116

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cell proliferation
Is the Subject Area "Cell proliferation" applicable to this article?

Thanks for your feedback.